Taysha Gene Therapies Inc (NASDAQ: TSHA) is -13.29% lower on its value in year-to-date trading and has touched a low of $1.19 and a high of $4.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TSHA stock was last observed hovering at around $1.48 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $1.50, the stock is -9.20% and -25.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 1.35% at the moment leaves the stock -34.54% off its SMA200. TSHA registered -0.66% loss for a year compared to 6-month loss of -32.13%. The firm has a 50-day simple moving average (SMA 50) of $2.0263 and a 200-day simple moving average (SMA200) of $2.2915.
The stock witnessed a -13.29% gain in the last 1 month and extending the period to 3 months gives it a -20.21%, and is -1.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.77% over the week and 7.79% over the month.
Taysha Gene Therapies Inc (TSHA) has around 52 employees, a market worth around $307.41M and $9.91M in sales. Profit margin for the company is -229.67%. Distance from 52-week low is 26.05% and -65.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.23%).
with sales reaching $2.05M over the same period.The EPS is expected to grow by 61.44% this year, but quarterly earnings will post -46.63% year-over-year. Quarterly sales are estimated to shrink -43.04% in year-over-year returns.
Taysha Gene Therapies Inc (TSHA) Top Institutional Holders
156.0 institutions hold shares in Taysha Gene Therapies Inc (TSHA), with institutional investors hold 94.65% of the company’s shares. The shares outstanding are 204.94M, and float is at 153.61M with Short Float at 15.59%. Institutions hold 77.29% of the Float.
The top institutional shareholder in the company is FMR LLC with over 21.21 million shares valued at $47.51 million. The investor’s holdings represent 9.1722% of the TSHA Shares outstanding. As of 2024-06-30, the second largest holder is RTW INVESTMENTS, LP with 18.8 million shares valued at $42.11 million to account for 8.1299 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 18.65 million shares representing 8.0649% and valued at over $41.78 million, while BLACKROCK INC. holds 5.0778 of the shares totaling 11.74 million with a market value of $26.3 million.
Taysha Gene Therapies Inc (TSHA) Insider Activity
The most recent transaction is an insider purchase by Manning Paul B, the company’s 10% Owner. SEC filings show that Manning Paul B bought 1,333,333 shares of the company’s common stock on Jun 27 ’24 at a price of $2.25 per share for a total of $3.0 million. Following the purchase, the insider now owns 1.33 million shares.
